Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

GlobeImmune

GlobeImmune News Editors

News Widget

Display the GlobeImmune news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

GlobeImmune News

News on GlobeImmune continually updated from thousands of sources around the net.

Feb 13, 2012 | The Boulder County Business Report

GlobeImmune tests new cancer drug

Drug and vaccine research company GlobeImmune Inc. is testing its new GI-6401 Tarmogen cancer drug in a study funded by the National Cancer Institute.

Comment?

Related Topix: Cancer, Health, National Cancer Institute, Charitable Organizations

Wed Feb 08, 2012

BioSpace

GlobeImmune, Inc. Initiates Phase 1 Clinical Trial of GI-6301 in Brachyury Expressing Cancers

LOUISVILLE, Colo., Feb. 8, 2012 - GlobeImmune, Inc. today announced the initiation of a Phase 1 clinical trial to be conducted at the National Cancer Institute to investigate the safety and tolerability of GI-6301, a new Tarmogen product, for patients with metastatic cancers containing brachyury protein.

Comment?

Related Topix: Louisville, CO, Immunology, Biology, Science

Los Angeles Jobs

Also on Topix